re: Ann: Neuren presentation to Arrowhead TBI... Neu is bound to rise substantially, purely on potential as it gets closer and closer to trial completion. Where is goes from this rise will be determined by trial results, but there will still be plenty of upside in anticipation.
Throw in added bonuses of persis and mild tbi etc, spikes will occur.
It's just some people choose to buy now at a discount and are willing to hold for medium to long term, where as others choose to wait and jump on board at a higher price.
I'm willing to put them in the drawer and pull them out in 12-18 months. At this point I'd probably sell 25% to pay for my original outlay and ride the rest through to completion.
Ann: Neuren presentation to Arrowhead TBI Confere, page-35
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.52 |
Change
0.310(2.04%) |
Mkt cap ! $1.983B | |||
| Open | High | Low | Value | Volume |
| $15.19 | $15.62 | $15.11 | $8.655M | 558.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 440 | $15.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.54 | 752 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |